Abstract
Recent genetic studies have implicated an active role for intrahepatic lipid accumulation in the pathogenesis of both polycystic ovary syndrome (PCOS) and cardiovascular disease. These new insights may provide novel (non)pharmacological opportunities for the prevention and treatment of PCOS and cardiovascular disease at both the societal and clinical level.
Original language | English |
---|---|
Journal | Trends in Endocrinology and Metabolism |
DOIs | |
Publication status | E-pub ahead of print - 1 Jan 2024 |
Keywords
- cardiovascular disease (CVD)
- fructose
- MASLD
- Mendelian randomization
- PCOS
- triangulation